Ignite Creation Date:
2024-05-06 @ 8:28 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02742324
Status:
COMPLETED
Last Update Posted:
2022-07-27
First Post:
2016-03-08
Brief Title:
Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-08
First Submit QC Date:
April 13 2016
Study First Post Date:
2016-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-26
Last Update Post Date:
2022-07-27
Last Update Post Date Type:
ACTUAL